Psoas abscess during treatment with intravenous tocilizumab in a patient with rheumatoid arthritis: a case-based review

Interleukin-6 receptor antagonist tocilizumab is a biologic drug used for treating patients with active rheumatoid arthritis (RA) who failed to respond to synthetic or other biologic disease-modifying antirheumatic drugs or where they were contraindicated. Interleukin-6 receptor blockade results in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vajdić, Ines Doko, Štimac, Goran, Pezelj, Ivan, Mustapić, Matej, Grazio, Simeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Case Based Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880036/
https://www.ncbi.nlm.nih.gov/pubmed/33576887
http://dx.doi.org/10.1007/s00296-021-04800-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880036/
https://www.ncbi.nlm.nih.gov/pubmed/33576887
http://dx.doi.org/10.1007/s00296-021-04800-y

Ejemplares similares